在活跃的性结肠炎中,对mirikizumab的反应的组织病理学预测因子
Ichitaro Horiuchi1, Akira Horiuchi2, Kaori Horiuchi3
1Department of Gastroenterology, Shinshu University Hospital, Matsumoto, Japan.
Clinical journal of gastroenterology
|March 6, 2026
概括
本病例系列显示,三名患者的mirikizumab有效治疗了性结肠炎 (UC). 使用Geboes 3.2级的组织学导向治疗确定了可能对IL-23抑制剂有反应的患者.
科学领域:
- 胃肠病学 胃肠病学
- 免疫学 免疫学 免疫学
- 组织病理学 组织病理学
背景情况:
- 性结肠炎 (UC) 是一种慢性炎症性肠病.
- 目前的治疗包括针对炎症途径的生物药物.
- 确定治疗反应的预测生物标志物仍然至关重要.
研究的目的:
- 报告成功使用mirikizumab治疗活跃的性结肠炎.
- 评估高上皮质中性友透 (Geboes 3.2级) 作为IL-23抑制剂反应预测生物标志物的实用性.
主要方法:
- 一个由三个患有活跃UC的患者组成的病例系列.
- 用Mirikizumab治疗,这是一个选择性的IL-23p19单克隆抗体.
- 对盖博斯3.2级 (高中性球菌透) 的结肠活检组织病理学评估.
主要成果:
- 这三名患者都获得了 mirikizumab.b 的成功治疗结果.
- 所有患者都表现出格博斯3.2级,表明IL-23/Th17驱动的炎症表型.
- 这些病例包括各种UC表现:急性严重胰腺炎,类固醇依赖的左侧UC和类固醇耐药UC.
结论:
- 米里基祖马布在治疗活性性结肠炎方面显示出潜在的疗效.
- 格博斯3.2级可能作为UC中对IL-23抑制剂反应的预测生物标志物.
- 组织学引导的生物选择可以优化UC患者的治疗策略.
更多相关视频
08:58Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
13.0K
07:38Multimodal Quantitative Phase Imaging with Digital Holographic Microscopy Accurately Assesses Intestinal Inflammation and Epithelial Wound Healing
Published on: September 13, 2016
8.8K
相关概念视频
Drugs for Treatment of Ulcerative Colitis in IBD
578
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
578
Inflammatory Bowel Disease I: Ulcerative Colitis
1.3K
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.3K
